Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
47.36 USD | -5.14% | +2.09% | -18.97% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.97% | 6.02B | |
-2.86% | 87.31B | |
+3.95% | 40.86B | |
-22.94% | 29.36B | |
+57.79% | 24.49B | |
-13.63% | 17.31B | |
-19.22% | 11.62B | |
-13.96% | 11.31B | |
-44.23% | 11.26B | |
+5.47% | 8.31B |
- Stock Market
- Equities
- APLS Stock
- News Apellis Pharmaceuticals, Inc.
- Apellis Pharmaceuticals : Credit Suisse Adjusts Apellis Pharmaceuticals's Price Target to $35 from $31, Keeps Neutral Rating